The fate of a cancer cure can lie in the destiny of a single resistant clone; this thought-provoking basic science work demonstrates, while pretherapy molecular variance is the root cause, differing resistance mechanisms play out depending on the timing and amount of therapeutic exposure. | Goyal, Nature 2023
